跳至主要内容
临床试验/NCT07594366
NCT07594366已完成不适用

Effectiveness of Suprainguinal Facia Iliaca Block in Maximizing the Feasibility of Positioning for Spinal Anesthesia in Patients With Hip and Proximal Femur Fractures, a Placebo Randomized Controlled Study

Suez Canal University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年9月1日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1

研究概览

简要总结

In this study, we assessed the effect of suprainguinal facia iliaca block in maximizing the feasibility of positioning for spinal anaesthesia in patients with hip and proximal femur fractures by determining the angle that could be achieved and success rate of spinal anesthesia The control group received a sham block with the same technique of suprainguinal fascia iliaca block before being given spinal anaesthesia.

The interventional group received suprainguinal fascia iliaca block before being given spinal anaesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

The patient and the caregiver were blinded to the injectate in the procedure. The investigator was blinded to the solution that was used for the block, as a third person had prepared the injectate.

The one who assessed the sitting angle was blinded to the group of the patient.

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients are ASA I (American Society of Anesthesiologists physical status grade I) = normal healthy patients, ASA II (American Society of Anesthesiologists physical status grade II) = patients with mild systemic disease and no functional limitations, or ASA III (American Society of Anesthesiologists physical status grade III) = patients with moderate systemic disease and some functional limitations.
  • Patients having hip and/or proximal femur fractures.

排除标准

  • Patient refusal to participate in the study
  • Patients' refusal for regional anaesthesia
  • Patients have other combined fractures rather than unilateral hip or proximal femur fractures.
  • Underlying coagulopathies.
  • Local infection.
  • Known allergy to LA.
  • Body mass index (BMI) more than 40 kg/m².
  • Heart block greater than first-degree.
  • Renal and hepatic dysfunction.
  • Neurological diseases such as Alzheimer's and dementia or apparent psychological instability.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdelrhman Alshawadfy

professor

Suez Canal University

研究点 (1)

Loading locations...

相似试验